Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study

被引：1
|
作者：
Liu, Jessica [1 ]
Chin-Yee, Benjamin [2 ]
Chin-Yee, Ian H. [2 ,3 ]
Ho, Jenny [2 ]
Sadikovic, Bekim [3 ]
Hsia, Cyrus C. [2 ,4 ]
机构：
[1] London Hlth Sci Ctr, Dept Med, London, ON, Canada
[2] London Hlth Sci Ctr, Dept Med, Div Hematol, London, ON, Canada
[3] London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON, Canada
[4] Victoria Hosp, Room E6 219A,800 Commissioners Rd, London, ON N6A5W9, Canada
来源：
JOURNAL OF INTERNAL MEDICINE | 2024年 / 295卷 / 01期
关键词：
D O I：
10.1111/joim.13722
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：103 / 105
页数：3
相关论文
共 50 条
  • [21] Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study
    Yi, Tae Won
    Atiquzzaman, Mohammad
    Zheng, Yuyan
    Smyth, Brendan
    Jardine, Meg
    Levin, Adeera
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2022, 9
  • [22] JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy
    Gangat, Naseema
    Szuber, Natasha
    Alkhateeb, Hassan
    Al-Kali, Aref
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2021, 138 (26) : 2886 - 2889
  • [23] Solution is not simple; sodium-glucose cotransporter-2 inhibitor use in Conn syndrome
    Soyaltin, Utku
    BLOOD PRESSURE MONITORING, 2024, 29 (04) : 195 - 197
  • [24] Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients
    Maigret, Lucie
    Basle, Lucile
    Chatelet, Valerie
    Ecotiere, Laure
    Perrin, Peggy
    Golbin, Leonard
    Bertrand, Dominique
    Anglicheau, Dany
    Poulain, Coralie
    Garrouste, Cyril
    Danthu, Clement
    Boud'hors, Charlotte
    Le Meur, Yannick
    Dekeyser, Manon
    Duthe, Fabien
    Sautenet, Benedicte
    Deliege, Pierre-Guillaume
    Gatault, Philippe
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 816 - 827
  • [25] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [26] Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database
    Imai, Takanori
    Kato, Naoto
    Kanda, Naoki
    Hashimoto, Hideki
    Yamana, Hayato
    Hatakeyama, Shuji
    DIABETES THERAPY, 2024, 15 (08) : 1821 - 1830
  • [27] Association of sodium-glucose cotransporter-2 inhibitor with regression of coronary plaque burden
    Zhang, T.
    Du, Y.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [28] Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Yu, Oriana H. Y.
    Chang, Yoosoo
    Cho, Juhee
    Sinn, Dong Hyun
    Cho, Young Min
    Shin, Ju-Young
    GUT, 2023, 72 (05) : 1020 - 1022
  • [29] Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors—a nationwide retrospective cohort study
    Wei-Syun Hu
    Cheng-Li Lin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 575 - 581
  • [30] Association between sodium-glucose cotransporter-2 (SGLT-2) inhibitors and lower extremity amputation: A retrospective cohort study
    Chang, Hsien-Yen
    Singh, Sonal
    Mansour, Omar
    Baksh, Sheriza
    Alexander, G. Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 485 - 485
12345